23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.
Business Model:
Revenue: $271.9M
Employees: 501-1,000
Address: 349 Oyster Point Blvd,
City: South San Francisco
State: CA
Zip: 94080
Country: US
23andMe is an online healthcare platform that provides DNA genetic testing for individuals and uses that information for health research.
Contact Phone:
+16509386300
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/17/2021
IPO Valuation:
$4B
Ticker Symbol:
ME
IPO Price:
$11/share
Amount Raised:
$592M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2015 | Doctor On Demand | Series B | 0 |
7/2015 | Doctor On Demand | Series B | 0 |
Announced Date | Name | Price |
---|---|---|
10/2021 | Lemonaid Health | |
7/2012 | CureTogether |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|